RESUMEN
Background: The severity of COVID-19 infection has an increasing trend in the elderly, which contributes to the high morbidity and mortality rates in this population. Aging itself is a prominent risk factor for severe disease and death from COVID-19. Case Description: This case report a 71-year-old woman who complained of shortness of breath for 3 days before being admitted to the hospital. Bilateral consolidation and increased bronchovascular pattern were found on chest radiograph, and a positive SARS-COV2 nasopharyngeal swab PCR test result was noted. This patient was diagnosed with confirmed severe manifestation of COVID-19, community-acquired pneumonia and type 1 respiratory failure, as well as type II diabetes mellitus and suspicion of acute gastritis. The results of the geriatric status assessment were moderate functional status, risk of malnutrition, and moderate risk of deep vein thrombosis (DVT). This patient underwent treatment in accordance with the COVID-19 protocol along with management for geriatric status improvement. The patient was given permission to return home after 14 days of treatment, during which time her health had improved and her functional status had changed to moderate dependency. During follow-up, the patient continued to receive therapy. She is still being observed and future evaluations will be conducted. Conclusion: The increased susceptibility of the elderly to COVID-19 infection is caused by various factors. A burden of death and long-term disability brought on by this pandemic may be lessened by new or modified therapies that target aging-associated mechanisms. Therefore, COVID-19 case management in this population should be done with a comprehensive approach.
RESUMEN
Summary Background. The Ministry of Health guidelines in Indonesia establish a protocol for administering vitamin D to people with COVID-19 as being 1,000 to 5,000 IU per day, both for adults and older adults. Objectives. This systematic review aims to investigate how much the optimal dose for patient COVID-19 within high-risk vitamin D deficiency is either geriatric population or have an underlying disease. Material and methods. A 32-year-old female patient came with positive RT-PCR nasopharyngeal swab with clinical anosmia with hypo-vitaminosis D, and a 60-year-old patient with shortness of breath and cough complaints, positive RT-PCR nasopharyngeal swab. Both patients were given 1,000 IU/day vitamin D. Results. A literature search was carried out from 2019 to 2021 on several search engines such as Pubmed, Clinical Trial.gov and Google Scholar. Four studies pooled and entered review synthesis. Conclusions. Supplementation with pulse dose vitamin D provides a clinically significant improvement, decreasing inflammatory cyto-kine markers in the non-geriatric population with hypovitaminosis. In the geriatric population, standard vitamin D has been shown to reduce the risk of frailty and worsening clinical features in COVID-19. As clinicians, it is important to enhance clinical awareness when recognising special populations with COVID-19 who require vitamin D supplementation above the guideline dose. © by Wydawnictwo Continuo.